Filing Details

Accession Number:
0001209191-15-026153
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-13 18:12:45
Reporting Period:
2015-03-12
Filing Date:
2015-03-13
Accepted Time:
2015-03-13 17:12:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
944809 Opko Health Inc. OPK Pharmaceutical Preparations (2834) 752402409
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356197 Adam Logal 4400 Biscayne Blvd.
Miami FL 33137
Sr. Vice President, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-12 60,000 $1.16 60,000 No 4 M Direct
Common Stock Disposition 2015-03-12 4,767 $14.60 55,233 No 4 F Direct
Common Stock Acquisiton 2015-03-12 35,000 $1.65 90,233 No 4 M Direct
Common Stock Disposition 2015-03-12 3,956 $14.60 86,277 No 4 F Direct
Common Stock Disposition 2015-03-13 24 $14.56 86,253 No 4 S Direct
Common Stock Disposition 2015-03-13 576 $14.61 85,677 No 4 S Direct
Common Stock Disposition 2015-03-13 500 $14.62 85,177 No 4 S Direct
Common Stock Disposition 2015-03-13 38,888 $14.64 46,289 No 4 S Direct
Common Stock Disposition 2015-03-13 1,500 $14.65 44,789 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-03-12 60,000 $0.00 60,000 $1.16
Common Stock Stock Option (Right to Buy) Disposition 2015-03-12 35,000 $0.00 35,000 $1.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-05-05 2016-05-04 No 4 M Direct
0 2012-04-28 2015-04-27 No 4 M Direct
Footnotes
  1. Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. The reporting person has retained the net number of shares issued upon the exercise of the option (55,233 shares).
  2. Closing market price of the Company's common stock on the transaction date.
  3. Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. The reporting person has retained the net number of shares issued upon the exercise of the option (31,044 shares).
  4. The reporting person sold the Common Stock to satisfy federal and/or state income tax obligations in connection with his acquisition of shares of OPKO Common Stock through net exercise on March 12, 2015.